# A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

> **NCT00521456** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 263 (actual)

## Conditions studied

- Cataract Extraction

## Interventions

- **DRUG:** ketorolac eye drops

## Key facts

- **NCT ID:** NCT00521456
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2009-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521456, "A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00521456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*